11-30233692-C-G
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PVS1_StrongPM2
The NM_001382289.1(FSHB):c.282C>G(p.Tyr94*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001382289.1 stop_gained
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001382289.1. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FSHB | MANE Select | c.282C>G | p.Tyr94* | stop_gained | Exon 3 of 3 | NP_001369218.1 | A0A0F7RQE8 | ||
| FSHB | c.282C>G | p.Tyr94* | stop_gained | Exon 3 of 3 | NP_000501.1 | P01225 | |||
| FSHB | c.282C>G | p.Tyr94* | stop_gained | Exon 3 of 3 | NP_001018090.1 | A0A0F7RQE8 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FSHB | TSL:1 MANE Select | c.282C>G | p.Tyr94* | stop_gained | Exon 3 of 3 | ENSP00000433424.1 | P01225 | ||
| FSHB | TSL:5 | c.282C>G | p.Tyr94* | stop_gained | Exon 3 of 3 | ENSP00000254122.3 | P01225 | ||
| FSHB | TSL:5 | c.282C>G | p.Tyr94* | stop_gained | Exon 3 of 3 | ENSP00000416606.1 | P01225 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.